Eppendorf reports growth in 2009

Eppendorf has published its annual report for 2009, highlighting its success in achieving business growth despite difficult economic conditions.

The science company’s net sales total for the year came to 433.2 million euros (362.3 million pounds) in 2009, an increase of 5.9 per cent compared to 2008, while earnings, income and cash flow were also up year-on-year.

According to Klaus Fink, Eppendorf’s chairman of the management board, this was achieved in part thanks to the firm’s growth in developing markets, as well as its close ties with the research community.

The company also predicted that its fortunes will improve further in the coming year, thanks to greater economic stability and the resilience of the life sciences market.

It said: “We expect to be able to further expand our market position and boost both sales and operating profit accordingly in fiscal years 2010 and 2011.”

Last month, Eppendorf launched a new range of LoBind tubes and plates, designed to allow safe and secure storage of biological samples.